Company / Profit Margin
Voyager Therapeutics, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
52.9%
FY2025
5-year range
-190.3% / 52.9%
FY2021-FY2025
Trend
+146.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -1158.8% in FY2020 to 52.9% in FY2025.
Based on SEC 10-K filings.
52.9% in FY2025 with a 5-year CAGR of +1211.7%.
Improved from -190.3% to 52.9% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +31.5pp
- 5-Year Change
- +1211.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 146.7% year-over-year.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 52.9% | +146.7% |
| FY2024 | -113.5% | +40.4% |
| FY2023 | -190.3% | -986.3% |
| FY2022 | 21.5% | +151.4% |
| FY2021 | -41.8% | +96.4% |
| FY2020 | -1158.8% | -66.1% |
| FY2019 | -697.6% | -146.8% |
| FY2018 | -282.6% | -65.1% |
| FY2017 | -171.2% | -81.9% |
| FY2016 | -94.1% | +36.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026